High materiality7/10
GeneDx price target raised to $63 from $50 at Piper Sandler
Why it may matterVerify against the original reporting
Upside potential supported by higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler raises WGS target to $63 from $50. The current price is about $55.42, suggesting roughly 14% upside.
- Target raised to $63; price ~$55.42; ~14% upside.
Key facts
- 01
Target: $63
- 02
Posted price: $55.42
- 03
Analyst firm: Piper Sandler
- 04
Analyst: David Westenberg
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.